Buy DSIP 10 mg + bacteriostatic water
€24.29
DSIP, 10 mg, with bacteriostatic water, is a synthetic WAGGDASGE nonapeptide format for analytical and in vitro laboratory research. Pharma Research .eu provides documented European supply subject to lot-specific purity and identity verification.
Buy DSIP, 10 mg + Bacteriostatic Water, for Advanced Laboratory Research in Europe
Delta sleep-inducing peptide (DSIP), also known as emideltide, is a synthetic linear nonapeptide used as a laboratory reagent in peptide analytics, neurophysiological model development and controlled in vitro investigations. The commonly reported sequence is H-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu-OH, abbreviated WAGGDASGE. Its reported formula is C₃₅H₄₈N₁₀O₁₅, with an average molecular mass of approximately 848.8 Da. Pharma Research .eu presents this 10 mg format with bacteriostatic water for qualified European laboratory teams.pubchem.ncbi.nlm.nih+2
Uncompromising Purity and Analytical Characterisation
DSIP should be specified as the free linear nonapeptide:
H-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu-OH
The free N-terminus and free C-terminal carboxylic acid should be stated explicitly. Amidated, acetylated, phosphorylated or salt-form variants should not be treated as equivalent because they can have different molecular masses, charge states, chromatographic retention and assay behaviour.
For laboratory procurement, the suitable target is ≥99.0% purity by RP-HPLC, subject to confirmation by the actual lot-specific certificate of analysis. Some research references report ≥99% HPLC purity, while others specify lower thresholds; the batch chromatogram and identity data should control acceptance.americanpeptides+1
A complete CoA should include:
-
RP-HPLC purity percentage, analytical method and chromatogram.
-
LC-MS, ESI-MS or high-resolution MS identity confirmation.
-
Sequence and terminal-group designation.
-
Free-peptide or salt-form information.
-
Molecular mass and principal molecular-ion assignment.
-
Visual appearance of the lyophilised material.
-
Residual-solvent results from synthesis and purification.
-
Water or residual-moisture content, where measured.
-
Heavy-metal or elemental-impurity results where included in the quality programme.
-
Lot number, manufacture date, retest date and storage requirements.
The commonly reported formula is C₃₅H₄₈N₁₀O₁₅, with an average molecular mass of approximately 848.8–848.81 g/mol and an exact mass near 848.3357 Da. CAS Registry Number 62568-57-4 is widely associated with the free peptide, although alternate registry entries appear in some databases. The supplier should therefore verify the exact form on the CoA.pubchem.ncbi.nlm.nih+2
DSIP is normally supplied as a white to off-white lyophilised powder. Visual inspection can identify gross discolouration, vial damage or visible contamination, but it cannot establish peptide identity or purity. Analytical release should combine visual assessment with RP-HPLC and mass-spectral confirmation.
Purity is important because DSIP is a small, acidic, glycine-rich peptide. Truncated sequences, altered terminal groups, synthesis by-products, counter-ions and residual moisture can affect retention time, ionisation, recovery and concentration calculations. Lower-grade or non-characterised material may be unsuitable for quantitative LC-MS, stability-indicating work or reproducible in vitro comparisons.
Bacteriostatic water is a separate reagent and should have its own label, expiry date, preservative information and documentation. Its excipients may influence chromatographic background, ionisation, pH, adsorption or cellular assay performance.
Principal Laboratory Applications and Research Methodologies
DSIP is suitable for controlled laboratory research involving nonapeptide chemistry, analytical characterisation and neurophysiological model development. All applications should be conducted by qualified personnel within an appropriately governed university, CRO, pharmaceutical R&D or analytical laboratory.
RP-HPLC and LC-MS method development. DSIP can serve as a defined low-molecular-weight peptide analyte for retention-time assignment, chromatographic optimisation and intact-mass confirmation. Its acidic residues and polar composition may require deliberate optimisation of mobile-phase pH, ionic strength and column chemistry.
Peptide identity and impurity profiling. Laboratories may monitor truncated products, oxidation or other degradation-related species using combined HPLC and mass spectrometry. A validated method should distinguish chemical degradation from adsorption, incomplete dissolution, matrix effects and instrument carryover.
Neurophysiological in vitro models. A verified DSIP lot may be incorporated into controlled cell-free or cellular assay systems examining peptide-associated electrophysiological, signalling or stress-response read-outs. Experimental plans should include vehicle controls, blank matrices, concentration confirmation and an assessment of whether bacteriostatic-water components influence the endpoint.
Reference and system-suitability work. A documented lot may support instrument checks, sample-recovery studies, calibration development and retention-time comparison. Unless formally certified under a recognised reference-material standard, it should be described as a research reference material or analytical reagent rather than a certified reference material.
The 10 mg quantity corresponds to approximately 11.8 µmol using the reported average molecular mass of 848.8 g/mol. A final concentration cannot be stated because the volume of bacteriostatic water was not specified. The actual concentration depends on final volume, purity, salt form, moisture content and the validated preparation method.
Bacteriostatic water should not automatically be assumed suitable for every analytical or cellular workflow. Laboratories should evaluate preservative effects using solvent blanks, matrix controls and cell-compatibility testing where relevant.
Compound Stability, Optimal Storage, and Safe Handling Protocols
DSIP should remain sealed in its lyophilised state until required for a validated laboratory procedure. Research references commonly recommend storing the dry peptide at or below −20°C, protected from light and moisture. Some supplier materials describe refrigerated conditions for short-term access, but the lot-specific CoA and stability programme should take precedence.americanpeptides+2
Recommended controls include:
-
Store unopened lyophilised DSIP at approximately −20°C unless the CoA specifies otherwise.
-
Keep the container tightly closed, dry and protected from direct light.
-
Allow a sealed vial to reach room temperature before opening to minimise condensation.
-
Use low-binding tubes where adsorption could affect recovery.
-
Prepare aliquots if repeated access is expected.
-
Store short-term aqueous solutions at 2–8°C only where validated.
-
Use frozen aliquots for longer-term solution storage when supported by stability data.
-
Avoid repeated freeze–thaw cycles.
-
Record solvent, concentration, preparation date, operator and storage history.
The sequence contains no methionine or cysteine, which may reduce susceptibility to certain oxidation pathways, but it does not guarantee solution stability. Hydrolysis, adsorption, pH-dependent changes and microbial or preservative-related effects remain possible. Stability should be assessed using chromatographic and mass-spectral measurements rather than appearance alone.
Reconstitution should be performed using a validated laboratory procedure. Add the aqueous reagent gradually, allow the powder to hydrate and mix gently. Avoid vigorous agitation unless shown to be compatible with the method. For quantitative work, confirm concentration and chromatographic integrity after preparation and any defined storage interval.
Handling should follow the current SDS and institutional chemical-risk assessment. Appropriate precautions generally include a certified fume hood or suitable local containment, nitrile gloves, safety goggles and a laboratory coat. Avoid aerosol generation and direct contact with the powder or solution. Dispose of contaminated materials through approved institutional chemical and laboratory-waste procedures.
Technical Specifications and Molecular Attributes
| Attribute | Specification |
|---|---|
| Product | DSIP, 10 mg, supplied with bacteriostatic water |
| Common designation | Delta sleep-inducing peptide; emideltide |
| Sequence | H-WAGGDASGE-OH |
| Residue count | 9 amino acids |
| IUPAC name | Full systematic peptide name should be confirmed on the CoA; sequence notation is preferred for procurement |
| CAS Registry Number | 62568-57-4 is widely reported; verify the exact form on the CoA |
| Molecular formula | C₃₅H₄₈N₁₀O₁₅ |
| Average molecular mass | Approximately 848.8–848.81 g/mol |
| Exact mass | Approximately 848.3357 Da |
| Physical state and colour | Lyophilised white to off-white powder |
| Solubility profile | Aqueous reconstitution may be feasible; solvent and buffer compatibility require assay-specific validation |
| Typical purity | Proposed target ≥99.0% by RP-HPLC; verify the actual lot-specific result |
| Identity testing | LC-MS, ESI-MS or high-resolution MS |
| Companion reagent | Bacteriostatic water; volume and formulation should be confirmed on the packaging |
| Long-term storage | Typically −20°C, sealed and protected from light and moisture |
The sequence, formula and molecular mass are supported by PubChem and specialist research references. Alternate CAS entries and conflicting supplier records mean that the CoA should control the final identity statement.pubchem.ncbi.nlm.nih+2
Pharma Research .eu: Your Premier EU Vendor for High-Purity Reagents
Pharma Research .eu can position DSIP as a documented European laboratory reagent for analytical chemists, biochemists, pharmacologists and laboratory managers requiring a defined nonapeptide. The product file should include a batch-specific CoA, SDS, sequence designation, purity result, identity data, terminal-group and salt-form information, and storage instructions.
Any claim that Pharma Research .eu operates an ISO 9001-certified quality-management system should be supported by a current certificate identifying the issuing body, scope and validity. Claims concerning discreet or temperature-controlled logistics across EU member states should likewise be verified for the destination, carrier route, packaging and applicable transport requirements.
A quality-focused supplier should be able to discuss:
-
DSIP’s WAGGDASGE sequence and free terminal groups.
-
Free-peptide versus salt-form molecular mass.
-
RP-HPLC purity and LC-MS identity testing.
-
Residual solvents, moisture and elemental-impurity reporting.
-
Packaging configuration and container-closure integrity.
-
Compatibility of bacteriostatic water with analytical workflows.
-
Storage, transport and documentation requirements.
Pharma Research .eu should therefore be described as a potential European source for research-grade DSIP, with vendor-specific certification and logistics claims verified through current records. The material is intended strictly for controlled laboratory research and analytical use by qualified personnel under applicable institutional procedures.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.


Reviews
There are no reviews yet.